Epilog Partners

Description

Epilog Partners is a private equity platform built by investors, operators and innovators for healthcare's complexity. It invests in tech-enabled payer and provider services and software and tech-enabled pharma services companies that are improving clinical, financial, and experiential outcomes. Epilog targets equity investments of $50 to $200 million in leveraged buyouts of profitable, high-growth companies. Its efforts are guided by a research centric, thesis driven approach that informs where to invest and how to maximize value. This approach has resulted in completed platform investments, add-on acquisitions, recapitalizations and liquidity events with an aggregate transaction value of over $6 billion. Portfolio Companies: Care Connectors, CareMetx and ReceptRx (exited)

Epilog Partners is a Dallas/Boston-based private equity firm targeting $50–$200M leveraged buyouts in tech-enabled payer and provider services and pharma-services outsourcing platforms. They have no current dental holdings but their healthcare-services platform buyout mandate makes them a plausible acquirer of dental or multi-site healthcare service platforms.

Epilog Partners is a private equity firm executing leveraged buyouts of $50–$200M in tech-enabled payer/provider services and pharma services platforms, with confirmed acquisitions (Care Connectors, CareMetx, ReceptRx) — a credible healthcare-services platform acquirer with clear mandate and capital to pursue dental or multi-site healthcare rollups.

enriched 2026-05-05

Financials